JP2015526441A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015526441A5 JP2015526441A5 JP2015527566A JP2015527566A JP2015526441A5 JP 2015526441 A5 JP2015526441 A5 JP 2015526441A5 JP 2015527566 A JP2015527566 A JP 2015527566A JP 2015527566 A JP2015527566 A JP 2015527566A JP 2015526441 A5 JP2015526441 A5 JP 2015526441A5
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- trifluoromethyl
- indazol
- benzoyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 59
- -1 nitro, hydroxy Chemical group 0.000 claims 34
- 125000003545 alkoxy group Chemical group 0.000 claims 31
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 31
- 229910052736 halogen Inorganic materials 0.000 claims 31
- 150000002367 halogens Chemical class 0.000 claims 31
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 25
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 16
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims 13
- 125000004043 oxo group Chemical group O=* 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 12
- 239000012453 solvate Substances 0.000 claims 12
- 125000003282 alkyl amino group Chemical group 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 3
- 239000005711 Benzoic acid Substances 0.000 claims 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 3
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 235000010233 benzoic acid Nutrition 0.000 claims 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 3
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 claims 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- FOCBRZYNWUYTNP-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(morpholine-4-carbonyl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C(=O)N2CCOCC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F FOCBRZYNWUYTNP-UHFFFAOYSA-N 0.000 claims 2
- 102000001691 Member 3 Group F Nuclear Receptor Subfamily 1 Human genes 0.000 claims 2
- 108010029279 Member 3 Group F Nuclear Receptor Subfamily 1 Proteins 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000005167 cycloalkylaminocarbonyl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- 125000004760 (C1-C4) alkylsulfonylamino group Chemical group 0.000 claims 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- 125000004845 (C1-C6) alkylsulfonylamino group Chemical group 0.000 claims 1
- CUJAFWQPUBJJEJ-UHFFFAOYSA-N 2-acetamido-4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]benzoic acid Chemical compound C1=C(C(O)=O)C(NC(=O)C)=CC(C=2C3=CC=CC=C3N(C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)N=2)=C1 CUJAFWQPUBJJEJ-UHFFFAOYSA-N 0.000 claims 1
- RQBDVVCZSCAYQL-UHFFFAOYSA-N 3-(4-carboxyphenyl)-1-[2-chloro-6-(trifluoromethyl)benzoyl]indazole-6-carboxylic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C(O)=O)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F RQBDVVCZSCAYQL-UHFFFAOYSA-N 0.000 claims 1
- FGSXFZVLHMWUDU-UHFFFAOYSA-N 3-fluoro-4-[1-(1-methylindole-2-carbonyl)indazol-3-yl]benzoic acid Chemical compound C=1C2=CC=CC=C2N(C)C=1C(=O)N(C1=CC=CC=C11)N=C1C1=CC=C(C(O)=O)C=C1F FGSXFZVLHMWUDU-UHFFFAOYSA-N 0.000 claims 1
- BPPONUKAAREGJL-UHFFFAOYSA-N 3-fluoro-4-[1-(2-methoxyacetyl)indazol-3-yl]benzoic acid Chemical compound C12=CC=CC=C2N(C(=O)COC)N=C1C1=CC=C(C(O)=O)C=C1F BPPONUKAAREGJL-UHFFFAOYSA-N 0.000 claims 1
- VWAYLDITYUHKSI-UHFFFAOYSA-N 3-fluoro-4-[1-(2-phenylpropanoyl)indazol-3-yl]benzoic acid Chemical compound C=1C=CC=CC=1C(C)C(=O)N(C1=CC=CC=C11)N=C1C1=CC=C(C(O)=O)C=C1F VWAYLDITYUHKSI-UHFFFAOYSA-N 0.000 claims 1
- URJOBDIUNWPXTR-UHFFFAOYSA-N 3-fluoro-4-[1-(naphthalene-1-carbonyl)indazol-3-yl]benzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=CC=CC2=CC=CC=C12 URJOBDIUNWPXTR-UHFFFAOYSA-N 0.000 claims 1
- RQLYGRRZWKTFLU-UHFFFAOYSA-N 3-fluoro-4-[1-(oxolane-2-carbonyl)indazol-3-yl]benzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1OCCC1 RQLYGRRZWKTFLU-UHFFFAOYSA-N 0.000 claims 1
- AHXGVYIRKMKSAV-UHFFFAOYSA-N 3-fluoro-4-[1-(pyridine-3-carbonyl)indazol-3-yl]benzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=CC=CN=C1 AHXGVYIRKMKSAV-UHFFFAOYSA-N 0.000 claims 1
- FEMMZTXFLFEFMF-UHFFFAOYSA-N 3-fluoro-4-[1-[2-(2-oxopyrrolidin-1-yl)acetyl]indazol-3-yl]benzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)CN1C(=O)CCC1 FEMMZTXFLFEFMF-UHFFFAOYSA-N 0.000 claims 1
- UFMFURBJBPRJFN-UHFFFAOYSA-N 3-fluoro-4-[1-[3-[(2-methylpropan-2-yl)oxycarbonyl]-3-azabicyclo[3.1.0]hexane-6-carbonyl]indazol-3-yl]benzoic acid Chemical compound C1N(C(=O)OC(C)(C)C)CC2C1C2C(=O)N(C1=CC=CC=C11)N=C1C1=CC=C(C(O)=O)C=C1F UFMFURBJBPRJFN-UHFFFAOYSA-N 0.000 claims 1
- MYRZEDFAAXWOCE-UHFFFAOYSA-N 4-[1-(1-benzofuran-7-carbonyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=CC=CC2=C1OC=C2 MYRZEDFAAXWOCE-UHFFFAOYSA-N 0.000 claims 1
- HLQBLHMEGINUEZ-UHFFFAOYSA-N 4-[1-(2,3-dihydro-1-benzofuran-7-carbonyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=CC=CC2=C1OCC2 HLQBLHMEGINUEZ-UHFFFAOYSA-N 0.000 claims 1
- ZQSOJGWWQMLPEG-UHFFFAOYSA-N 4-[1-(2,3-dihydro-1h-indene-4-carbonyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=CC=CC2=C1CCC2 ZQSOJGWWQMLPEG-UHFFFAOYSA-N 0.000 claims 1
- KNXIOXOXYSMFDK-UHFFFAOYSA-N 4-[1-(2-bromo-3-chlorobenzoyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=CC=CC(Cl)=C1Br KNXIOXOXYSMFDK-UHFFFAOYSA-N 0.000 claims 1
- VQYAVXSWJIEBDY-UHFFFAOYSA-N 4-[1-(2-bromo-3-methylbenzoyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound CC1=CC=CC(C(=O)N2C3=CC=CC=C3C(C=3C(=CC(=CC=3)C(O)=O)F)=N2)=C1Br VQYAVXSWJIEBDY-UHFFFAOYSA-N 0.000 claims 1
- BCDKQBWCSBECKY-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclobutylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3,5-difluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC(F)=C1C(C1=NC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CCC1 BCDKQBWCSBECKY-UHFFFAOYSA-N 0.000 claims 1
- CKFNTMBCGYATAC-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclobutylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CCC1 CKFNTMBCGYATAC-UHFFFAOYSA-N 0.000 claims 1
- RDQQWHRZYWLWJC-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclopentylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CCCC1 RDQQWHRZYWLWJC-UHFFFAOYSA-N 0.000 claims 1
- RUPATPKYIMISQN-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclopropylbenzoyl)-4-fluoroindazol-3-yl]-3,5-difluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC(F)=C1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 RUPATPKYIMISQN-UHFFFAOYSA-N 0.000 claims 1
- ITAJZCHZGRGIEJ-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclopropylbenzoyl)-4-fluoroindazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 ITAJZCHZGRGIEJ-UHFFFAOYSA-N 0.000 claims 1
- AAADBGOEWPPOQQ-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclopropylbenzoyl)indazol-3-yl]-3,5-difluorobenzoic acid Chemical compound ClC1=C(C(=O)N2N=C(C3=CC=CC=C23)C2=C(C=C(C(=O)O)C=C2F)F)C(=CC=C1)C1CC1 AAADBGOEWPPOQQ-UHFFFAOYSA-N 0.000 claims 1
- CSTNVZNXJBJIAB-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclopropylbenzoyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 CSTNVZNXJBJIAB-UHFFFAOYSA-N 0.000 claims 1
- AMQKIZZEIKBRFO-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclopropylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3,5-difluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC(F)=C1C(C1=NC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 AMQKIZZEIKBRFO-UHFFFAOYSA-N 0.000 claims 1
- LMIWUTKCGKCAPR-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclopropylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 LMIWUTKCGKCAPR-UHFFFAOYSA-N 0.000 claims 1
- NAJJOZBHQMYRCQ-UHFFFAOYSA-N 4-[1-(2-chloro-6-cyclopropylbenzoyl)pyrrolo[3,2-b]pyridin-3-yl]-3,5-difluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC(F)=C1C(C1=NC=CC=C11)=CN1C(=O)C1=C(Cl)C=CC=C1C1CC1 NAJJOZBHQMYRCQ-UHFFFAOYSA-N 0.000 claims 1
- XQLORDGAAKKHJV-UHFFFAOYSA-N 4-[1-(2-chloro-6-methyl-4-morpholin-4-ylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound CC1=CC(N2CCOCC2)=CC(Cl)=C1C(=O)N(C1=CC=CN=C11)N=C1C1=CC=C(C(O)=O)C=C1F XQLORDGAAKKHJV-UHFFFAOYSA-N 0.000 claims 1
- MRUIGUAOGXKSOD-UHFFFAOYSA-N 4-[1-(2-chloro-6-morpholin-4-ylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1N1CCOCC1 MRUIGUAOGXKSOD-UHFFFAOYSA-N 0.000 claims 1
- STTDKBXVHRDKSV-UHFFFAOYSA-N 4-[1-(2-chloro-6-prop-1-en-2-ylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound CC(=C)C1=CC=CC(Cl)=C1C(=O)N1C2=CC=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=N1 STTDKBXVHRDKSV-UHFFFAOYSA-N 0.000 claims 1
- SZTKTFVKDORSMX-UHFFFAOYSA-N 4-[1-(4-amino-2-chloro-6-methylbenzoyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound CC1=CC(N)=CC(Cl)=C1C(=O)N1C2=CC=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=N1 SZTKTFVKDORSMX-UHFFFAOYSA-N 0.000 claims 1
- ULGRACMCPGVEEK-UHFFFAOYSA-N 4-[1-(6-chloro-2,3-dihydro-1,4-benzodioxine-5-carbonyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC2=C1OCCO2 ULGRACMCPGVEEK-UHFFFAOYSA-N 0.000 claims 1
- ULWLHAACQVHNPR-UHFFFAOYSA-N 4-[1-[2-(dimethylamino)-6-methylbenzoyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound CN(C)C1=CC=CC(C)=C1C(=O)N1C2=CC=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=N1 ULWLHAACQVHNPR-UHFFFAOYSA-N 0.000 claims 1
- OEJKIMIEMMNCSZ-UHFFFAOYSA-N 4-[1-[2-chloro-4-(2-methoxyethoxy)-6-methylbenzoyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound ClC1=CC(OCCOC)=CC(C)=C1C(=O)N1C2=CC=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=N1 OEJKIMIEMMNCSZ-UHFFFAOYSA-N 0.000 claims 1
- BIUDEVDBTBYDTN-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-2-methylindol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC=CC=C2N(C(=O)C=2C(=CC=CC=2Cl)C(F)(F)F)C(C)=C1C1=CC=C(C(O)=O)C=C1F BIUDEVDBTBYDTN-UHFFFAOYSA-N 0.000 claims 1
- IIYPHUTYQFNHTA-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-4-formylindazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=C(C=O)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F IIYPHUTYQFNHTA-UHFFFAOYSA-N 0.000 claims 1
- LDWYFJQKADHORK-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-5-(methylamino)pyrrolo[2,3-c]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C1=2C=NC(NC)=CC=2C(C=2C(=CC(=CC=2)C(O)=O)F)=CN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F LDWYFJQKADHORK-UHFFFAOYSA-N 0.000 claims 1
- ZAFJKTHLHAQPER-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-5-[(2-methylpropan-2-yl)oxycarbonylamino]pyrrolo[2,3-c]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C1=2C=NC(NC(=O)OC(C)(C)C)=CC=2C(C=2C(=CC(=CC=2)C(O)=O)F)=CN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F ZAFJKTHLHAQPER-UHFFFAOYSA-N 0.000 claims 1
- VWLWIRYLQWWKSU-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1,3-oxazinane-3-carbonyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=C(C=C11)C(=O)N2COCCC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F VWLWIRYLQWWKSU-UHFFFAOYSA-N 0.000 claims 1
- MUIQMFMWWHLGBL-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1,3-oxazol-2-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2OC=CN=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F MUIQMFMWWHLGBL-UHFFFAOYSA-N 0.000 claims 1
- NTVUUWMYIXCQPR-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1,3-oxazole-2-carbonyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=C(C=C11)C(=O)C=2OC=CN=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F NTVUUWMYIXCQPR-UHFFFAOYSA-N 0.000 claims 1
- ZXYDLCCOBGDIMX-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1,3-oxazolidine-3-carbonyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=C(C=C11)C(=O)N2COCC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F ZXYDLCCOBGDIMX-UHFFFAOYSA-N 0.000 claims 1
- SOLIBFAOUSRRQU-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1,3-thiazol-4-yl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2N=CSC=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F SOLIBFAOUSRRQU-UHFFFAOYSA-N 0.000 claims 1
- JJOYOICIYBODAK-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1,3-thiazol-5-yl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2SC=NC=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F JJOYOICIYBODAK-UHFFFAOYSA-N 0.000 claims 1
- NACDHOZIQUKVIW-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1-methylimidazol-2-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound CN1C=CN=C1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 NACDHOZIQUKVIW-UHFFFAOYSA-N 0.000 claims 1
- FLOCZDVOIMRSCY-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1-methylimidazol-4-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound CN1C=NC(C=2C=C3N(C(=O)C=4C(=CC=CC=4Cl)C(F)(F)F)N=C(C3=CC=2)C=2C(=CC(=CC=2)C(O)=O)F)=C1 FLOCZDVOIMRSCY-UHFFFAOYSA-N 0.000 claims 1
- AOMVCSGXIXOKEM-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(1-methylimidazol-4-yl)indazol-3-yl]benzoic acid Chemical compound CN1C=NC(C=2C=C3N(C(=O)C=4C(=CC=CC=4Cl)C(F)(F)F)N=C(C3=CC=2)C=2C=CC(=CC=2)C(O)=O)=C1 AOMVCSGXIXOKEM-UHFFFAOYSA-N 0.000 claims 1
- YNUXZWMHLUWWNJ-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2,5-dioxoimidazolidin-4-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C2C(NC(=O)N2)=O)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F YNUXZWMHLUWWNJ-UHFFFAOYSA-N 0.000 claims 1
- DAEJUPFLIPARNN-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2-cyanophenyl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2C(=CC=CC=2)C#N)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F DAEJUPFLIPARNN-UHFFFAOYSA-N 0.000 claims 1
- MSZHHRWWKYFYFC-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2-fluorophenyl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2C(=CC=CC=2)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F MSZHHRWWKYFYFC-UHFFFAOYSA-N 0.000 claims 1
- KMGXHZZOYQXJDZ-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2-methoxyethylamino)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(NCCOC)=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F KMGXHZZOYQXJDZ-UHFFFAOYSA-N 0.000 claims 1
- BPUYMKDBEOEQSL-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2-methylpyrazol-3-yl)indazol-3-yl]benzoic acid Chemical compound CN1N=CC=C1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C=CC(=CC=3)C(O)=O)C2=C1 BPUYMKDBEOEQSL-UHFFFAOYSA-N 0.000 claims 1
- OXMNNYUNKCFBCA-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2-oxo-3h-1,3,4-oxadiazol-5-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2OC(=O)NN=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F OXMNNYUNKCFBCA-UHFFFAOYSA-N 0.000 claims 1
- BVGRJQDXWMSWJI-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2-oxoazetidin-1-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)N2C(CC2)=O)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F BVGRJQDXWMSWJI-UHFFFAOYSA-N 0.000 claims 1
- QUQZHZHXCYMLID-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2-oxoimidazolidin-1-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)N2C(NCC2)=O)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F QUQZHZHXCYMLID-UHFFFAOYSA-N 0.000 claims 1
- KJHFTRVYJRRVMF-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(2-oxopyrrolidin-1-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)N2C(CCC2)=O)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F KJHFTRVYJRRVMF-UHFFFAOYSA-N 0.000 claims 1
- NVEKLBBZRYVJMB-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3,5-dimethylmorpholine-4-carbonyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound CC1COCC(C)N1C(=O)C1=CN=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 NVEKLBBZRYVJMB-UHFFFAOYSA-N 0.000 claims 1
- ZLXRSGDRVFGXDV-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-cyanophenyl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2C=C(C=CC=2)C#N)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F ZLXRSGDRVFGXDV-UHFFFAOYSA-N 0.000 claims 1
- UCTLSJKSGDDWPA-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-fluorophenyl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2C=C(F)C=CC=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F UCTLSJKSGDDWPA-UHFFFAOYSA-N 0.000 claims 1
- LRVWMBOXODREIZ-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-hydroxyazetidin-1-yl)indazol-3-yl]benzoic acid Chemical compound C1C(O)CN1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C=CC(=CC=3)C(O)=O)C2=C1 LRVWMBOXODREIZ-UHFFFAOYSA-N 0.000 claims 1
- PMPPBNRULNNWNW-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-hydroxybut-1-ynyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(C#CC(O)C)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F PMPPBNRULNNWNW-UHFFFAOYSA-N 0.000 claims 1
- CXGPIKIGNUXFFU-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-hydroxyprop-1-ynyl)indazol-3-yl]benzoic acid Chemical compound C12=CC(C#CCO)=CC=C2C(C=2C=CC(=CC=2)C(O)=O)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F CXGPIKIGNUXFFU-UHFFFAOYSA-N 0.000 claims 1
- RBBOZTVVJHOOLW-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-hydroxypyrrolidin-1-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound C1C(O)CCN1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 RBBOZTVVJHOOLW-UHFFFAOYSA-N 0.000 claims 1
- QWGWQRAYHKIEDH-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-methoxyazetidine-1-carbonyl)indol-3-yl]-3-fluorobenzoic acid Chemical compound C1C(OC)CN1C(=O)C1=CC=C(C(=CN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 QWGWQRAYHKIEDH-UHFFFAOYSA-N 0.000 claims 1
- OXCXRHIUCVUGLH-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-methyl-1,2,4-oxadiazol-5-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound CC1=NOC(C=2C=C3N(C(=O)C=4C(=CC=CC=4Cl)C(F)(F)F)N=C(C3=CC=2)C=2C(=CC(=CC=2)C(O)=O)F)=N1 OXCXRHIUCVUGLH-UHFFFAOYSA-N 0.000 claims 1
- QBKOGSWXVFYMQO-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-methyl-2-oxoimidazolidin-1-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound O=C1N(C)CCN1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 QBKOGSWXVFYMQO-UHFFFAOYSA-N 0.000 claims 1
- WFIGKMLTRWQOHK-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-methylimidazol-4-yl)indazol-3-yl]benzoic acid Chemical compound CN1C=NC=C1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C=CC(=CC=3)C(O)=O)C2=C1 WFIGKMLTRWQOHK-UHFFFAOYSA-N 0.000 claims 1
- AVRWBKUYFIKANO-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(3-methylmorpholine-4-carbonyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound CC1COCCN1C(=O)C1=CN=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 AVRWBKUYFIKANO-UHFFFAOYSA-N 0.000 claims 1
- NCRZXDLOGZVMMH-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(4-cyanophenyl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2C=CC(=CC=2)C#N)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F NCRZXDLOGZVMMH-UHFFFAOYSA-N 0.000 claims 1
- JHZRWXUYINHMEA-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(4-fluorophenyl)indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2C=CC(F)=CC=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F JHZRWXUYINHMEA-UHFFFAOYSA-N 0.000 claims 1
- IXANPMZGKWYZFR-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(4-oxopiperidine-1-carbonyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C(=O)N2CCC(=O)CC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F IXANPMZGKWYZFR-UHFFFAOYSA-N 0.000 claims 1
- DOGGFBCVMGBQGM-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(5-methyl-1,3,4-oxadiazol-2-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound O1C(C)=NN=C1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 DOGGFBCVMGBQGM-UHFFFAOYSA-N 0.000 claims 1
- SQPYZFSEMVSKBI-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(5-methyl-1,3-oxazol-2-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound O1C(C)=CN=C1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 SQPYZFSEMVSKBI-UHFFFAOYSA-N 0.000 claims 1
- CXGHMXSAPRQXIK-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(5-methylthiophen-3-yl)indazol-3-yl]benzoic acid Chemical compound Cc1cc(cs1)-c1ccc2c(nn(C(=O)c3c(Cl)cccc3C(F)(F)F)c2c1)-c1ccc(cc1)C(O)=O CXGHMXSAPRQXIK-UHFFFAOYSA-N 0.000 claims 1
- BTUVDHKIRBWMFA-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(N'-cyano-N,N-dimethylcarbamimidoyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(C(=NC#N)N(C)C)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F BTUVDHKIRBWMFA-UHFFFAOYSA-N 0.000 claims 1
- CUBIWDUMSWMMRZ-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(cyclopropanecarbonyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=C(C=C11)C(=O)C2CC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F CUBIWDUMSWMMRZ-UHFFFAOYSA-N 0.000 claims 1
- GBVSQIMQCOMFQI-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(cyclopropanecarbonylamino)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(NC(=O)C2CC2)C=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F GBVSQIMQCOMFQI-UHFFFAOYSA-N 0.000 claims 1
- JJRGEGKNUNIBHX-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(cyclopropylamino)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(NC2CC2)C=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F JJRGEGKNUNIBHX-UHFFFAOYSA-N 0.000 claims 1
- XJLOMCIFVCBGQP-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(cyclopropylcarbamoyl)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=NC=C(C=C11)C(=O)NC2CC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F XJLOMCIFVCBGQP-UHFFFAOYSA-N 0.000 claims 1
- PTLLLSCDEUROFR-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(methanesulfonamido)indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(NS(=O)(=O)C)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F PTLLLSCDEUROFR-UHFFFAOYSA-N 0.000 claims 1
- NMXIJMPFGPBHGZ-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(methanesulfonamidomethyl)indazol-3-yl]benzoic acid Chemical compound C12=CC(CNS(=O)(=O)C)=CC=C2C(C=2C=CC(=CC=2)C(O)=O)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F NMXIJMPFGPBHGZ-UHFFFAOYSA-N 0.000 claims 1
- DYONLPUIJFGZCB-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(methoxycarbonylamino)indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(NC(=O)OC)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F DYONLPUIJFGZCB-UHFFFAOYSA-N 0.000 claims 1
- YJYCOMGZRKWOHW-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(methylamino)pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(NC)=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F YJYCOMGZRKWOHW-UHFFFAOYSA-N 0.000 claims 1
- FLHPZKAVRBMTRL-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(methylcarbamoylamino)indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(NC(=O)NC)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F FLHPZKAVRBMTRL-UHFFFAOYSA-N 0.000 claims 1
- ZROFOIOPEPLZAW-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(oxetan-3-yl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C2COC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F ZROFOIOPEPLZAW-UHFFFAOYSA-N 0.000 claims 1
- ARZXKYMGJALLBA-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(oxetan-3-ylamino)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(NC2COC2)C=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F ARZXKYMGJALLBA-UHFFFAOYSA-N 0.000 claims 1
- WHGQARDUXBSUDH-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(NC(=O)OC(C)(C)C)=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F WHGQARDUXBSUDH-UHFFFAOYSA-N 0.000 claims 1
- FYCDYBZKAVRDMF-GASCZTMLSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[(2r,6s)-2,6-dimethylmorpholine-4-carbonyl]indazol-3-yl]-3-fluorobenzoic acid Chemical compound C1[C@@H](C)O[C@@H](C)CN1C(=O)C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 FYCDYBZKAVRDMF-GASCZTMLSA-N 0.000 claims 1
- IAHCCNRIJKPZTM-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[2-(dimethylamino)-2-oxoethyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(CC(=O)N(C)C)=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F IAHCCNRIJKPZTM-UHFFFAOYSA-N 0.000 claims 1
- FBVPAOCGDMHZAL-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[2-(methylamino)-2-oxoethyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(CC(=O)NC)=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F FBVPAOCGDMHZAL-UHFFFAOYSA-N 0.000 claims 1
- DBLOLXXKJOBMTA-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[5-(hydroxymethyl)-1,3-oxazol-2-yl]indazol-3-yl]-3-fluorobenzoic acid Chemical compound O1C(CO)=CN=C1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C(=CC(=CC=3)C(O)=O)F)C2=C1 DBLOLXXKJOBMTA-UHFFFAOYSA-N 0.000 claims 1
- MHRAJUWMBYVALM-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[cyclopropyl(hydroxy)methyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C=1N=C2C(C=3C(=CC(=CC=3)C(O)=O)F)=NN(C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C2=CC=1C(O)C1CC1 MHRAJUWMBYVALM-UHFFFAOYSA-N 0.000 claims 1
- KPPSRVSRXSXIEN-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[cyclopropyl(methyl)carbamoyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C=1N=C2C(C=3C(=CC(=CC=3)C(O)=O)F)=NN(C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C2=CC=1C(=O)N(C)C1CC1 KPPSRVSRXSXIEN-UHFFFAOYSA-N 0.000 claims 1
- WDPHOVASCHHXHY-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[hydroxy(1,3-oxazol-2-yl)methyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C=1N=C2C(C=3C(=CC(=CC=3)C(O)=O)F)=NN(C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C2=CC=1C(O)C1=NC=CO1 WDPHOVASCHHXHY-UHFFFAOYSA-N 0.000 claims 1
- PLUSZQBSIICZOQ-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-[methyl(methylcarbamoyl)amino]indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(N(C)C(=O)NC)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F PLUSZQBSIICZOQ-UHFFFAOYSA-N 0.000 claims 1
- KIKXTRLDPJWURJ-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-ethynylindazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C#C)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F KIKXTRLDPJWURJ-UHFFFAOYSA-N 0.000 claims 1
- PAOBWZISCVUZCX-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-morpholin-4-ylindazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)N2CCOCC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F PAOBWZISCVUZCX-UHFFFAOYSA-N 0.000 claims 1
- VEBWPAOCBSLAJK-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-pyridin-2-ylindazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2N=CC=CC=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F VEBWPAOCBSLAJK-UHFFFAOYSA-N 0.000 claims 1
- UUUDMJKDJAOEQW-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-pyridin-4-ylindazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2C=CN=CC=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F UUUDMJKDJAOEQW-UHFFFAOYSA-N 0.000 claims 1
- CDDTUWDAFLCGTE-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-pyrimidin-2-ylindazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2N=CC=CN=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F CDDTUWDAFLCGTE-UHFFFAOYSA-N 0.000 claims 1
- RSRHBRNRWCKXDN-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-pyrimidin-4-ylindazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2N=CN=CC=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F RSRHBRNRWCKXDN-UHFFFAOYSA-N 0.000 claims 1
- YERMLAHIZLWWBF-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]pyrazolo[4,3-b]pyridin-3-yl]-1h-indazole-7-carboxylic acid Chemical compound C1=2C=NNC=2C(C(=O)O)=CC=C1C(C1=NC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F YERMLAHIZLWWBF-UHFFFAOYSA-N 0.000 claims 1
- RWCUCCDRSMFEAJ-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]pyrazolo[4,3-b]pyridin-3-yl]-2-(methanesulfonamido)benzoic acid Chemical compound C1=C(C(O)=O)C(NS(=O)(=O)C)=CC(C=2C3=NC=CC=C3N(C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)N=2)=C1 RWCUCCDRSMFEAJ-UHFFFAOYSA-N 0.000 claims 1
- SDAFCQOHKWKKHV-GORDUTHDSA-N 4-[1-[2-chloro-6-[(e)-prop-1-enyl]benzoyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C\C=C\C1=CC=CC(Cl)=C1C(=O)N1C2=CC=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=N1 SDAFCQOHKWKKHV-GORDUTHDSA-N 0.000 claims 1
- NEPVVYYXRPGDHG-UHFFFAOYSA-N 4-[2-methyl-1-[2-(trifluoromethyl)benzoyl]indol-3-yl]benzoic acid Chemical compound CC=1N(C2=CC=CC=C2C1C1=CC=C(C(=O)O)C=C1)C(C1=C(C=CC=C1)C(F)(F)F)=O NEPVVYYXRPGDHG-UHFFFAOYSA-N 0.000 claims 1
- ALIZPFBIRRYJQJ-UHFFFAOYSA-N 4-[4-chloro-1-(2-chloro-6-cyclopropylbenzoyl)indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=C(Cl)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 ALIZPFBIRRYJQJ-UHFFFAOYSA-N 0.000 claims 1
- RPWHNSYDDRMDCE-UHFFFAOYSA-N 4-[5-acetamido-1-[2-chloro-6-(trifluoromethyl)benzoyl]pyrrolo[2,3-c]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C1=2C=NC(NC(=O)C)=CC=2C(C=2C(=CC(=CC=2)C(O)=O)F)=CN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F RPWHNSYDDRMDCE-UHFFFAOYSA-N 0.000 claims 1
- SNVCUFWHSXCXFG-UHFFFAOYSA-N 4-[6-(2-amino-2-oxoethyl)-1-[2-chloro-6-(trifluoromethyl)benzoyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(CC(=O)N)=CN=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F SNVCUFWHSXCXFG-UHFFFAOYSA-N 0.000 claims 1
- FWXDCINMHCWFAU-UHFFFAOYSA-N 4-[6-(2-carboxyethylamino)-1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(NCCC(=O)O)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F FWXDCINMHCWFAU-UHFFFAOYSA-N 0.000 claims 1
- OLJHROKPTPBUPY-UHFFFAOYSA-N 4-[6-(3-aminoprop-1-ynyl)-1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(C#CCN)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F OLJHROKPTPBUPY-UHFFFAOYSA-N 0.000 claims 1
- FBJVFVUDDUPHAU-UHFFFAOYSA-N 4-[6-(5-bromo-1,3-oxazol-2-yl)-1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C=2OC(Br)=CN=2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F FBJVFVUDDUPHAU-UHFFFAOYSA-N 0.000 claims 1
- GOWRWZBVFKBQBE-UHFFFAOYSA-N 4-[6-(azetidin-1-yl)-1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)N2CCC2)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F GOWRWZBVFKBQBE-UHFFFAOYSA-N 0.000 claims 1
- LPBGSTHUDBPARL-UHFFFAOYSA-N 4-[6-(azetidine-1-carbonyl)-1-[2-chloro-6-(trifluoromethyl)benzoyl]indol-3-yl]-3-fluorobenzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C(C1=CC=C(C=C11)C(=O)N2CCC2)=CN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F LPBGSTHUDBPARL-UHFFFAOYSA-N 0.000 claims 1
- MGTVGJZJGNRVRA-UHFFFAOYSA-N 4-[6-[2-(azetidin-1-yl)-2-oxoethyl]-1-[2-chloro-6-(trifluoromethyl)benzoyl]pyrazolo[4,3-b]pyridin-3-yl]-3-fluorobenzoic acid Chemical compound OC(=O)c1ccc(-c2nn(C(=O)c3c(Cl)cccc3C(F)(F)F)c3cc(CC(=O)N4CCC4)cnc23)c(F)c1 MGTVGJZJGNRVRA-UHFFFAOYSA-N 0.000 claims 1
- XSLPFBFEJUJHTN-UHFFFAOYSA-N 4-[6-[4-(aminomethyl)pyridin-2-yl]-1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]benzoic acid Chemical compound NCC1=CC=NC(C=2C=C3N(C(=O)C=4C(=CC=CC=4Cl)C(F)(F)F)N=C(C3=CC=2)C=2C=CC(=CC=2)C(O)=O)=C1 XSLPFBFEJUJHTN-UHFFFAOYSA-N 0.000 claims 1
- FICCBHFYEHKBFR-UHFFFAOYSA-N 4-[6-[acetyl(methyl)amino]-1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(N(C(C)=O)C)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F FICCBHFYEHKBFR-UHFFFAOYSA-N 0.000 claims 1
- OWNZPMDXFBUQRT-UHFFFAOYSA-N 4-[6-acetamido-1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]-3-fluorobenzoic acid Chemical compound C12=CC(NC(=O)C)=CC=C2C(C=2C(=CC(=CC=2)C(O)=O)F)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F OWNZPMDXFBUQRT-UHFFFAOYSA-N 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- QSULMPTZHVPLTB-UHFFFAOYSA-N C=CC1=CC=CC(Cl)=C1C(N(C1=CC=CN=C11)N=C1C(C(F)=CC=C1)=C1C(O)=O)=O Chemical compound C=CC1=CC=CC(Cl)=C1C(N(C1=CC=CN=C11)N=C1C(C(F)=CC=C1)=C1C(O)=O)=O QSULMPTZHVPLTB-UHFFFAOYSA-N 0.000 claims 1
- UDKQNQVOBNAWDO-UHFFFAOYSA-N CN(C1=CC=C2C(C(C(F)=CC=C3)=C3C(O)=O)=NN(C(C(C(C(F)(F)F)=CC=C3)=C3Cl)=O)C2=C1)S(C)(=O)=O Chemical compound CN(C1=CC=C2C(C(C(F)=CC=C3)=C3C(O)=O)=NN(C(C(C(C(F)(F)F)=CC=C3)=C3Cl)=O)C2=C1)S(C)(=O)=O UDKQNQVOBNAWDO-UHFFFAOYSA-N 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000011200 Kawasaki disease Diseases 0.000 claims 1
- 102000016978 Orphan receptors Human genes 0.000 claims 1
- 108070000031 Orphan receptors Proteins 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000033 alkoxyamino group Chemical group 0.000 claims 1
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 claims 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000004452 carbocyclyl group Chemical group 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 claims 1
- 125000005169 cycloalkylcarbonylamino group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 201000000626 mucocutaneous leishmaniasis Diseases 0.000 claims 1
- 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 102000003702 retinoic acid receptors Human genes 0.000 claims 1
- 108090000064 retinoic acid receptors Proteins 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- HZRYIXOKVCFEHC-UHFFFAOYSA-M sodium;4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]-6-(5-methyl-1,3-oxazol-2-yl)indazol-3-yl]benzoate Chemical compound [Na+].O1C(C)=CN=C1C1=CC=C(C(=NN2C(=O)C=3C(=CC=CC=3Cl)C(F)(F)F)C=3C=CC(=CC=3)C([O-])=O)C2=C1 HZRYIXOKVCFEHC-UHFFFAOYSA-M 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2012/080131 WO2014026327A1 (en) | 2012-08-15 | 2012-08-15 | 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof |
| CNPCT/CN2012/080131 | 2012-08-15 | ||
| PCT/US2013/054887 WO2014028589A2 (en) | 2012-08-15 | 2013-08-14 | 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015526441A JP2015526441A (ja) | 2015-09-10 |
| JP2015526441A5 true JP2015526441A5 (enExample) | 2016-09-23 |
| JP6422438B2 JP6422438B2 (ja) | 2018-11-14 |
Family
ID=50101185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015527566A Expired - Fee Related JP6422438B2 (ja) | 2012-08-15 | 2013-08-14 | ＲＯＲγＴ阻害剤としての４−ヘテロアリール置換安息香酸化合物およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9745265B2 (enExample) |
| EP (1) | EP2884981B1 (enExample) |
| JP (1) | JP6422438B2 (enExample) |
| KR (1) | KR20150042266A (enExample) |
| AU (1) | AU2013302725A1 (enExample) |
| BR (1) | BR112015003188A2 (enExample) |
| CA (1) | CA2881688A1 (enExample) |
| IN (1) | IN2015DN01156A (enExample) |
| MX (1) | MX2015001941A (enExample) |
| RU (1) | RU2015108894A (enExample) |
| WO (2) | WO2014026327A1 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2487159A1 (en) | 2011-02-11 | 2012-08-15 | MSD Oss B.V. | RorgammaT inhibitors |
| WO2014026327A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof |
| WO2014026328A1 (en) * | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof |
| WO2014026329A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof |
| WO2014026330A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| WO2015095795A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE, AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE |
| JP6466461B2 (ja) | 2014-02-03 | 2019-02-06 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | Ｒｏｒガンマのジヒドロピロロピリジン阻害剤 |
| US10532088B2 (en) | 2014-02-27 | 2020-01-14 | Lycera Corporation | Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods |
| WO2015139621A1 (zh) * | 2014-03-18 | 2015-09-24 | 北京韩美药品有限公司 | 4-杂芳基取代的苯甲酸或苯甲酰胺类化合物 |
| US9896441B2 (en) | 2014-05-05 | 2018-02-20 | Lycera Corporation | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease |
| US10189777B2 (en) | 2014-05-05 | 2019-01-29 | Lycera Corporation | Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease |
| TW201617314A (zh) * | 2014-09-10 | 2016-05-16 | 第一三共股份有限公司 | 羧酸衍生物 |
| WO2016044067A1 (en) * | 2014-09-15 | 2016-03-24 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
| EP3207043B3 (en) * | 2014-10-14 | 2019-10-02 | Vitae Pharmaceuticals, LLC | Dihydropyrrolopyridine inhibitors of ror-gamma |
| GB201419015D0 (en) | 2014-10-24 | 2014-12-10 | Orca Pharmaceuticals Ltd | Compounds |
| US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| US9845308B2 (en) | 2014-11-05 | 2017-12-19 | Vitae Pharmaceuticals, Inc. | Isoindoline inhibitors of ROR-gamma |
| MA41179A (fr) | 2014-12-19 | 2017-10-24 | Cancer Research Tech Ltd | Composés inhibiteurs de parg |
| EP3242878B1 (en) * | 2015-01-08 | 2020-10-14 | Impetis Biosciences Ltd. | Bicyclic compounds, compositions and medicinal applications thereof |
| CA2975997A1 (en) * | 2015-02-11 | 2016-08-18 | Merck Sharp & Dohme Corp. | Substituted pyrazole compounds as rorgammat inhibitors and uses thereof |
| WO2016145298A1 (en) | 2015-03-12 | 2016-09-15 | The Regents Of The University Of California | METHODS FOR TREATING CANCER WITH RORgamma INHIBITORS |
| US10421751B2 (en) | 2015-05-05 | 2019-09-24 | Lycera Corporation | Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease |
| WO2016201225A1 (en) | 2015-06-11 | 2016-12-15 | Lycera Corporation | Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of rory and the treatment of disease |
| EP3331876B1 (en) | 2015-08-05 | 2020-10-07 | Vitae Pharmaceuticals, LLC | Modulators of ror-gamma |
| CA3129180A1 (en) * | 2015-09-21 | 2017-03-30 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
| EP3368535B1 (en) * | 2015-10-27 | 2020-12-02 | Merck Sharp & Dohme Corp. | Heteroaryl substituted benzoic acids as rorgammat inhibitors and uses thereof |
| WO2017075178A1 (en) * | 2015-10-27 | 2017-05-04 | Merck Sharp & Dohme Corp. | SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| US10287272B2 (en) | 2015-10-27 | 2019-05-14 | Merck Sharp & Dohme Corp. | Substituted indazole compounds as RORgammaT inhibitors and uses thereof |
| JP6914257B2 (ja) | 2015-11-20 | 2021-08-04 | ヴァイティー ファーマシューティカルズ，エルエルシー | Ｒｏｒ−ガンマのモジュレーター |
| CN109310671B (zh) * | 2016-01-21 | 2021-08-06 | 淄博百极常生制药有限公司 | 布鲁顿酪氨酸激酶抑制剂 |
| TW202220968A (zh) | 2016-01-29 | 2022-06-01 | 美商維它藥物有限責任公司 | ＲＯＲ－γ調節劑 |
| US9481674B1 (en) | 2016-06-10 | 2016-11-01 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
| HUE059242T2 (hu) * | 2016-07-29 | 2022-11-28 | Rapt Therapeutics Inc | Azetidin-származékok mint kemokin receptor modulátorok és felhasználásuk |
| US11628159B2 (en) | 2017-01-10 | 2023-04-18 | Eth Zurich | Cell-protective compounds and their use |
| JP7090639B2 (ja) | 2017-04-11 | 2022-06-24 | サンシャイン・レイク・ファーマ・カンパニー・リミテッド | フッ素置換されたインダゾール化合物及びその使用 |
| WO2018219797A1 (en) | 2017-06-02 | 2018-12-06 | Basf Se | Substituted oxadiazoles for combating phytopathogenic fungi |
| WO2019023207A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | Inhibitors of rorϒ |
| WO2019018975A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF ROR GAMMA |
| WO2019178079A1 (en) | 2018-03-12 | 2019-09-19 | Abbvie Inc. | Inhibitors of tyrosine kinase 2 mediated signaling |
| GB201811825D0 (en) * | 2018-07-19 | 2018-09-05 | Benevolentai Bio Ltd | Organic compounds |
| US11780843B2 (en) * | 2020-03-31 | 2023-10-10 | Nuevolution A/S | Compounds active towards nuclear receptors |
| CN117043162A (zh) * | 2021-05-19 | 2023-11-10 | 迈巴制药(南京)有限公司 | Tyk2选择性抑制剂及其用途 |
| AU2023239344A1 (en) | 2022-03-23 | 2024-10-10 | Ideaya Biosciences, Inc. | Piperazine substituted indazole compounds as inhibitors of parg |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670447A (en) | 1983-08-22 | 1987-06-02 | Hoechst-Roussel Pharmaceuticals Inc. | Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles |
| PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
| US5639780A (en) | 1995-05-22 | 1997-06-17 | Merck Frosst Canada, Inc. | N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors |
| US6133290A (en) | 1998-07-31 | 2000-10-17 | Eli Lilly And Company | 5-HT1F agonists |
| GB0117577D0 (en) | 2001-02-16 | 2001-09-12 | Aventis Pharm Prod Inc | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands |
| US7355042B2 (en) | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| AU2005271737A1 (en) | 2004-08-03 | 2006-02-16 | Wyeth | Indazoles useful in treating cardiovascular diseases |
| CA2583428A1 (en) | 2004-09-03 | 2006-03-09 | Plexxikon, Inc. | Bicyclic heteroaryl pde4b inhibitors |
| SE0402762D0 (sv) | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Indazole sulphonamide derivatives |
| CN100516049C (zh) | 2004-11-16 | 2009-07-22 | 永信药品工业股份有限公司 | 抗血管生成药n2-(取代的芳基甲基)-3-(取代的苯基)吲唑的合成 |
| EP1828180A4 (en) | 2004-12-08 | 2010-09-15 | Glaxosmithkline Llc | 1H-pyrrolo [2,3-BETA] PYRIDINE |
| MX2008010481A (es) | 2006-02-17 | 2008-12-19 | Memory Pharm Corp | Compuestos que tienen afinado para el receptor f-ht6. |
| JP4675801B2 (ja) | 2006-03-06 | 2011-04-27 | 日本メナード化粧品株式会社 | Ｒｏｒ活性化剤 |
| EP2001880A2 (en) | 2006-03-07 | 2008-12-17 | Array Biopharma, Inc. | Heterobicyclic pyrazole compounds and methods of use |
| GB0611587D0 (en) | 2006-06-12 | 2006-07-19 | Glaxo Group Ltd | Novel compounds |
| PL2134685T3 (pl) | 2007-04-16 | 2016-02-29 | Abbvie Inc | Pochodne indolu niepodstawione w pozycji 7 jako inhibitory Mcl-1 |
| GB0708141D0 (en) | 2007-04-26 | 2007-06-06 | Syngenta Participations Ag | Improvements in or relating to organic compounds |
| AR067326A1 (es) | 2007-05-11 | 2009-10-07 | Novartis Ag | Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido |
| BRPI0812450A2 (pt) | 2007-06-05 | 2019-09-24 | Schering Corp | derivados de indazol policíclicos e seu uso como inibidores de erk para o tratamento de câncer |
| US20100317863A1 (en) | 2007-07-25 | 2010-12-16 | Boehringer Ingelheim International Gmbh | Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof |
| WO2010050837A1 (ru) | 2008-10-28 | 2010-05-06 | Haskin Lev Yakovlevich | Ветроэнергетическая установка |
| EP2181710A1 (en) * | 2008-10-28 | 2010-05-05 | Phenex Pharmaceuticals AG | Ligands for modulation of orphan receptor-gamma (NR1F3) activity |
| EP3037421A3 (en) | 2008-11-25 | 2016-11-30 | University Of Rochester | Mlk inhibitors and methods of use |
| WO2010150837A1 (ja) | 2009-06-25 | 2010-12-29 | 第一三共株式会社 | インドリン誘導体 |
| US20130017188A1 (en) | 2009-07-31 | 2013-01-17 | The Brigham And Women's Hospital, Inc. | Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
| CN102770429A (zh) | 2009-12-18 | 2012-11-07 | 詹森药业有限公司 | 用作雌激素相关受体-α调节剂的取代的氨基噻唑酮吲唑 |
| CN102883602B (zh) | 2010-02-16 | 2017-07-18 | Uwm研究基金会有限公司 | 降低细菌的毒力的方法 |
| EP2571361A4 (en) | 2010-05-19 | 2013-11-13 | Univ North Carolina | PYRAZOLOPYRIMIDINE COMPOUNDS FOR CANCER TREATMENT |
| EP2638014B1 (en) * | 2010-11-08 | 2017-01-04 | Lycera Corporation | N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of ror-gamma activity and the treatment of diseases |
| KR20120063283A (ko) | 2010-12-07 | 2012-06-15 | 제일약품주식회사 | 신규한 피라졸로 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물 |
| BR112013015854B1 (pt) | 2010-12-22 | 2019-07-02 | Ludwig-Maximilians-Universistät München | Processos para produzir reagentes de organozinco e compostos orgânicos, composição de reagentes de organozinco e complexo de coordenação de zinco |
| EP2487159A1 (en) * | 2011-02-11 | 2012-08-15 | MSD Oss B.V. | RorgammaT inhibitors |
| JP2014166961A (ja) | 2011-06-20 | 2014-09-11 | Dainippon Sumitomo Pharma Co Ltd | 新規インダゾール誘導体 |
| WO2014026328A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof |
| WO2014026329A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof |
| WO2014026330A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| WO2014026327A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof |
-
2012
- 2012-08-15 WO PCT/CN2012/080131 patent/WO2014026327A1/en not_active Ceased
-
2013
- 2013-08-14 BR BR112015003188A patent/BR112015003188A2/pt not_active IP Right Cessation
- 2013-08-14 JP JP2015527566A patent/JP6422438B2/ja not_active Expired - Fee Related
- 2013-08-14 KR KR1020157006322A patent/KR20150042266A/ko not_active Withdrawn
- 2013-08-14 AU AU2013302725A patent/AU2013302725A1/en not_active Abandoned
- 2013-08-14 US US14/421,048 patent/US9745265B2/en active Active
- 2013-08-14 RU RU2015108894A patent/RU2015108894A/ru unknown
- 2013-08-14 EP EP13829282.6A patent/EP2884981B1/en active Active
- 2013-08-14 MX MX2015001941A patent/MX2015001941A/es unknown
- 2013-08-14 CA CA2881688A patent/CA2881688A1/en not_active Abandoned
- 2013-08-14 WO PCT/US2013/054887 patent/WO2014028589A2/en not_active Ceased
-
2015
- 2015-02-12 IN IN1156DEN2015 patent/IN2015DN01156A/en unknown
-
2017
- 2017-07-12 US US15/647,437 patent/US10196354B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015526441A5 (enExample) | ||
| RU2015108894A (ru) | СОЕДИНЕНИЯ 4-ГЕТЕРОАРИЛЗАМЕЩЕННОЙ БЕНЗОЙНОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ RORгаммаТ И ИХ ПРИМЕНЕНИЯ | |
| JP6862033B2 (ja) | Ｇｐｒ１２０アゴニストとしてのビアリール誘導体 | |
| HRP20171991T1 (hr) | Derivati pirolidin karbonske kiseline kao agonisti g-protein spojenog receptora (gpr43), farmaceutski pripravak i postupci za primjenu u liječenju poremećaja metabolizma | |
| JP6054869B2 (ja) | 複素環化合物 | |
| JP2019537571A5 (enExample) | ||
| JP2021500345A5 (enExample) | ||
| JP2017500364A5 (enExample) | ||
| JP2010508338A5 (enExample) | ||
| JP2010539186A5 (enExample) | ||
| TW201831464A (zh) | 作為激酶抑制劑之雜環醯胺 | |
| JP2017526711A5 (enExample) | ||
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| CA2873060A1 (en) | Nampt inhibitors | |
| HRP20170622T1 (hr) | Derivati piridinila i kondenziranog piridinil triazolona | |
| JP2019505595A5 (enExample) | ||
| WO2014181287A1 (en) | Heterocyclyl compounds and uses thereof | |
| JP2016506964A5 (ja) | ナトリウムチャネルの調節剤としてのキノリンおよびキノキサリンアミド | |
| RU2017116598A (ru) | Соединения и композиции для модуляции киназной активности мутантов egfr | |
| TW200529830A (en) | A thiazole derivative | |
| JP2010533158A5 (enExample) | ||
| JP2016512515A5 (enExample) | ||
| JP2010539188A5 (enExample) | ||
| JP2014531465A5 (enExample) | ||
| JP2010539187A5 (enExample) |